JPS4992217A - - Google Patents

Info

Publication number
JPS4992217A
JPS4992217A JP48051535A JP5153573A JPS4992217A JP S4992217 A JPS4992217 A JP S4992217A JP 48051535 A JP48051535 A JP 48051535A JP 5153573 A JP5153573 A JP 5153573A JP S4992217 A JPS4992217 A JP S4992217A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP48051535A
Other languages
Japanese (ja)
Other versions
JPS5526124B2 (en, 2012
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4992217A publication Critical patent/JPS4992217A/ja
Publication of JPS5526124B2 publication Critical patent/JPS5526124B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
JP5153573A 1972-05-10 1973-05-09 Expired JPS5526124B2 (en, 2012)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7216616A FR2183546B1 (en, 2012) 1972-05-10 1972-05-10

Publications (2)

Publication Number Publication Date
JPS4992217A true JPS4992217A (en, 2012) 1974-09-03
JPS5526124B2 JPS5526124B2 (en, 2012) 1980-07-11

Family

ID=9098254

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5153573A Expired JPS5526124B2 (en, 2012) 1972-05-10 1973-05-09

Country Status (17)

Country Link
US (1) US3950508A (en, 2012)
JP (1) JPS5526124B2 (en, 2012)
AR (1) AR203268A1 (en, 2012)
BE (1) BE799331A (en, 2012)
CA (1) CA1041906A (en, 2012)
DD (1) DD104027A5 (en, 2012)
DE (1) DE2323686A1 (en, 2012)
DK (1) DK137706B (en, 2012)
FI (1) FI56623C (en, 2012)
FR (1) FR2183546B1 (en, 2012)
GB (1) GB1421964A (en, 2012)
HU (1) HU168307B (en, 2012)
IL (1) IL42232A (en, 2012)
IN (1) IN139518B (en, 2012)
NL (1) NL158388B (en, 2012)
OA (1) OA04380A (en, 2012)
ZA (1) ZA733188B (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5112920A (en, 2012) * 1974-06-07 1976-01-31 Alza Corp

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4985017A (en) * 1981-07-13 1991-01-15 Alza Corporation Parenteral therapeutical system comprising drug cell
EP0094116A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung
AU581177B2 (en) * 1983-05-31 1989-02-16 Choong-Gook Jang Dry direct compression compositions for controlled release dosage forms
JPS60104804A (ja) * 1983-11-09 1985-06-10 Nippon Ferrite Ltd エア抜き装置
JPS60104805A (ja) * 1983-11-09 1985-06-10 Nippon Ferrite Ltd エア抜き装置
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
US4810501A (en) * 1986-06-17 1989-03-07 Warner-Lambert Company Sustained release pharmaceutical preparations
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5135757A (en) * 1988-09-19 1992-08-04 Edward Mendell Co., Inc. Compressible sustained release solid dosage forms
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
CH685978A5 (fr) * 1991-01-30 1995-11-30 Wellcome Found Comprimes dispersables dans l'eau.
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
KR0168715B1 (ko) * 1992-11-30 1999-01-15 밋첼 아이. 커시너 맛을 차단하는 약제학적 조성물
IL119660A (en) * 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
FR2760190B1 (fr) * 1997-02-28 1999-04-09 Adir Composition pharmaceutique pour la liberation programmee de dexfenfluramine
IN186245B (en, 2012) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
DK1041987T3 (da) 1997-12-22 2006-08-21 Euro Celtique Sa Oral farmaceutisk doseringsform omfattende en kombination af en opioid-agonist og naltrexon
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
AUPQ573300A0 (en) 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
EP1387673B1 (en) 2001-05-11 2010-12-29 Endo Pharmaceuticals Inc. Abuse-resistant controlled-release opioid dosage form
KR20040098050A (ko) * 2002-04-05 2004-11-18 유로-셀띠끄 소시에떼 아노님 옥시코돈 및 날록손을 포함하는 약제학적 제제
US20050019397A1 (en) * 2003-07-23 2005-01-27 Jacobs Richard L. Cellulosic fiber containing composition
ATE407693T1 (de) * 2004-03-22 2008-09-15 Solvay Pharm Gmbh Orale pharmazeutische zusammensetzungen von produkten mit lipase, insbesondere von pankreatin,mit tensiden
EP1604667A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the restless leg syndrome
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EA015615B1 (ru) * 2005-01-28 2011-10-31 Еуро-Селтик С.А. Устойчивые к спиртам лекарственные формы
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
EP1695700A1 (en) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Dosage form containing oxycodone and naloxone
US20070148151A1 (en) 2005-07-29 2007-06-28 Martin Frink Processes for the manufacture and use of pancreatin
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US20240226249A9 (en) * 2005-08-15 2024-07-11 AbbVie Pharmaceuticals GmbH Controlled release pharmaceutical compositions for acid-labile drugs
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20070286903A1 (en) * 2006-06-13 2007-12-13 Becicka Brian T Composition and method for taste masking
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
NZ590952A (en) * 2008-07-07 2012-09-28 Euro Celtique Sa Use of opioid antagonists for treating urinary retention
WO2010103039A1 (en) 2009-03-10 2010-09-16 Euro-Celtique S.A. Immediate release pharmaceutical compositions comprising oxycodone and naloxone
KR20160034352A (ko) 2013-07-23 2016-03-29 유로-셀티큐 에스.에이. 장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2993836A (en) * 1958-02-20 1961-07-25 Dow Chemical Co Sustained release tablets
US2980589A (en) * 1958-09-12 1961-04-18 American Cyanamid Co Process for producing anhydrous granulation of a medicinally active waterlabile powder
US3079303A (en) * 1958-12-11 1963-02-26 Smith Kline French Lab Basic tablet granulation and process of using same
FR1473805A (fr) * 1959-10-01 1967-03-24 Merck & Co Inc Véhicule pharmaceutique
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
US3453360A (en) * 1966-04-27 1969-07-01 Abbott Lab Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3507952A (en) * 1968-12-20 1970-04-21 Smithkline Corp Sustained release bolus for animal husbandry
GB1359643A (en) * 1970-09-28 1974-07-10 Controlled Medications Controlled release medicament
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3773921A (en) * 1971-11-15 1973-11-20 Hoffmann La Roche Therapeutic compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5112920A (en, 2012) * 1974-06-07 1976-01-31 Alza Corp

Also Published As

Publication number Publication date
FI56623C (fi) 1980-03-10
IL42232A (en) 1976-08-31
IL42232A0 (en) 1973-07-30
JPS5526124B2 (en, 2012) 1980-07-11
GB1421964A (en) 1976-01-21
AU5531473A (en) 1974-11-07
FR2183546A1 (en, 2012) 1973-12-21
FR2183546B1 (en, 2012) 1975-06-20
DK137706C (en, 2012) 1982-11-15
BE799331A (fr) 1973-11-09
OA04380A (fr) 1980-02-15
NL7306422A (en, 2012) 1973-11-13
FI56623B (fi) 1979-11-30
HU168307B (en, 2012) 1976-03-28
DE2323686A1 (de) 1973-11-22
DK137706B (da) 1978-04-24
ZA733188B (en) 1975-01-29
CA1041906A (fr) 1978-11-07
NL158388B (nl) 1978-11-15
DD104027A5 (en, 2012) 1974-02-20
IN139518B (en, 2012) 1976-06-26
AR203268A1 (es) 1975-08-29
US3950508A (en) 1976-04-13

Similar Documents

Publication Publication Date Title
DK137706C (en, 2012)
JPS5517342B2 (en, 2012)
JPS5336502B2 (en, 2012)
NO134903C (en, 2012)
JPS497947U (en, 2012)
JPS4969400A (en, 2012)
JPS4972161A (en, 2012)
JPS5015814B2 (en, 2012)
FR2236543A1 (en, 2012)
JPS4973835A (en, 2012)
JPS4979102A (en, 2012)
RO59758A2 (en, 2012)
CH572563A5 (en, 2012)
CH570781A5 (en, 2012)
CH573464A5 (en, 2012)
CH573033A5 (en, 2012)
CH572964A5 (en, 2012)
CH573529A5 (en, 2012)
CH579967A5 (en, 2012)
CH572561A5 (en, 2012)
CH583036A5 (en, 2012)
CH583042A5 (en, 2012)
CH571657A5 (en, 2012)
CH579599A5 (en, 2012)
SE7114029L (en, 2012)